Results 241 to 250 of about 287,756 (345)

Combining Procalcitonin and Calcitonin for the Diagnosis of Medullary Thyroid Cancer: A Two‐Step Approach

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Calcitonin (CT) represents the most important biochemical marker of medullary thyroid cancer (MTC), but has certain limits. Procalcitonin (ProCT) has been recognized as an alternative or additional marker for MTC. The aim of the study is to evaluate prospectively the role of ProCT combined with CT in the identification of MTC ...
Cristina Clausi   +13 more
wiley   +1 more source

Intrathyroidal Fifth Parathyroid Adenoma: A Rare Cause of Primary Hyperparathyroidism. [PDF]

open access: yesJCEM Case Rep
Rusnak AJ   +5 more
europepmc   +1 more source

‘Case of the Month’ from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus

open access: yes
BJU International, EarlyView.
James P. Blackmur   +10 more
wiley   +1 more source

CD105 (Endoglin) Expression as a Prognostic Marker in Aggressive Papillary Thyroid Carcinoma

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Background Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy, with a generally favourable prognosis. However, a subset of PTC cases exhibit aggressive behaviour, including lymph node and distant organ metastases. Identifying biomarkers that can differentiate between benign and malignant lesions, as well as predict
İlker Çordan, Tuğba Günler
wiley   +1 more source

Home - About - Disclaimer - Privacy